Engineered endolysin-based "artilysins" for controlling the gram-negative pathogen Helicobacter pylori
Dengyuan Xu1,2, Shanshan Zhao2, Jun Dou1,2
1China Pharmaceutical University, Nanjing, 211100, China.
New artilysins, combining endolysin and holin enzymes, effectively target and destroy Helicobacter pylori. This novel approach offers a promising solution for eradicating the bacteria, addressing antibiotic resistance challenges in gastrointestinal disease treatment.
Area of Science:
- Microbiology
- Biotechnology
- Drug Discovery
Background:
- Helicobacter pylori infections are linked to gastrointestinal diseases and gastric cancer.
- Antibiotic resistance in H. pylori necessitates novel therapeutic strategies.
- Bacterial viruses (phages) offer potential antimicrobial agents like endolysins and holins.
Purpose of the Study:
- To develop a novel antimicrobial agent effective against H. pylori.
- To overcome the challenge of H. pylori's outer membrane barrier.
- To investigate the efficacy of genetically engineered artilysins.
Main Methods:
- Genetic linkage of endolysin and holin enzymes to create artilysins.
- Expression of artilysins in Escherichia coli.
- In vitro bacteriostasis assays and electron microscopy for H. pylori analysis.
Main Results:
- Purified artilysins demonstrated potent bacteriostatic effects on H. pylori.
- Electron microscopy confirmed artilysins perforated and destroyed the H. pylori cell surface.
- Artilysins exhibited significant bacteriolytic activity against H. pylori.
Conclusions:
- Artilysins are effective in eradicating H. pylori by targeting its cell wall and membrane.
- Engineered artilysins represent a promising new therapeutic approach for H. pylori infections.
- This strategy overcomes the outer membrane barrier inherent to Gram-negative bacteria like H. pylori.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists


